EUVIMEDEUVIMED entdecken
Crossref

The value of radioembolisation therapy on metastatic liver tumours – a single centre experience

Ozgul Ekmekcioglu, Umut Erdem, Pelin Arican, Hikmet Ozvar, Ozgur Bostanci

Nuklearmedizin - NuclearMedicine · 01.06.2023 · 62 (03) · 214-219

DOI: 10.1055/a-2026-0851 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nuklearmedizin - NuclearMedicine, erschienen am 01.06.2023. Verfasst von Ozgul Ekmekcioglu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Nuclear Medicine, University of Health Sciences, Sisli Hamidiye Etfal Training and Research Hospital, Istanbul, Turkiye. Hauptthemen laut MEDLINE: Liver Neoplasms, Carcinoma, Hepatocellular. Die Arbeit nennt 29 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Local treatments used in metastatic liver tumours efficiently control the disease and survival. Transarterial radioembolisation (TARE) is a safely used locoregional treatment method. We aim to investigate the impact of TARE on different kinds of metastatic liver tumours and the effect of pre-treatment clinical findings. Material and Methods The patients with metastatic liver tumours referred to our department for radioembolisation were retrospectively evaluated. All patients were given a Y-90 glass microsphere after being selected by the appropriate clinical and imaging criteria, lung shunt fraction levels, vascular investigation, and macro aggregated albumin (MAA) scintigraphy performed in the angiography unit.

Results

Thirty-four (17 women, 17 men) patients were suitable for the treatment. Patients were treated with 115.88±47.84 Gy Y-90 glass Microspheres. The mean survival rate was 14.59±12.59 months after treatment. Higher survival rates were detected in patients who had higher pre-treatment serum albumin levels. The optimum cut-off value of albumin to predict response to treatment was 4 g/dl with 88.89% sensitivity, 62.50% specificity, 72.73% PPV and 83.33% NPV. Furthermore, one unit increase in age increased mortality 1.152 times in our patient group.

Conclusion

Radioembolisation is a safe and efficient method for controlling metastatic liver disease. Albumin levels significantly affect predicting response; higher albumin levels are related to higher survival rates. Furthermore, older age positively correlated with mortality rates in our patient group.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver NeoplasmsCarcinoma, HepatocellularMaleHumansFemaleYttrium RadioisotopesRetrospective StudiesAlbuminsMicrospheresTechnetium Tc 99m Aggregated Albumin

Substanzen

Yttrium-90Yttrium RadioisotopesAlbuminsTechnetium Tc 99m Aggregated Albumin

Autor:innen und Institutionen

  • Nuclear Medicine, University of Health Sciences, Sisli Hamidiye Etfal Training and Research Hospital, Istanbul, Turkiye.
  • Interventional Radiology Department, University of Health Sciences, Sisli Hamidiye Etfal Training and Research Hospital, Istanbul, Turkiye.
  • Radiation Oncology, University of Health Sciences, Sisli Hamidiye Etfal Training and Research Hospital, Istanbul, Turkiye.
  • Hepatobiliary and General Surgery, University of Health Sciences, Sisli Hamidiye Etfal Training and Research Hospital, Istanbul, Turkiye.

Zitieren

APA

Ekmekcioglu, O., Erdem, U., Arican, P., Ozvar, H., & Bostanci, O. (2023). The value of radioembolisation therapy on metastatic liver tumours – a single centre experience. Nuklearmedizin - NuclearMedicine, 62(03), 214-219. https://doi.org/10.1055/a-2026-0851

Vancouver

Ekmekcioglu O, Erdem U, Arican P, Ozvar H, Bostanci O. The value of radioembolisation therapy on metastatic liver tumours – a single centre experience. Nuklearmedizin - NuclearMedicine. 2023;62(03):214-219. doi:10.1055/a-2026-0851

BibTeX
@article{Ekmekcioglu2023,
  author = {Ekmekcioglu, Ozgul and Erdem, Umut and Arican, Pelin and Ozvar, Hikmet and Bostanci, Ozgur},
  title = {The value of radioembolisation therapy on metastatic liver tumours – a single centre experience},
  journal = {Nuklearmedizin - NuclearMedicine},
  year = {2023},
  volume = {62},
  number = {03},
  pages = {214--219},
  doi = {10.1055/a-2026-0851}
}
Kostenlos starten →